These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31695005)

  • 1. [Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].
    Ueno S; Nozaki J; Kusano S; Kawano Y; Kikukawa Y; Okuno Y; Hata H; Matsuoka M; Uchiba M
    Rinsho Ketsueki; 2019; 60(10):1443-1448. PubMed ID: 31695005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency.
    Ishida F; Okubo K; Ito T; Okumura N; Souri M; Ichinose A
    Thromb Haemost; 2010 Dec; 104(6):1284-5. PubMed ID: 20941461
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
    Krumdieck R; Shaw DR; Huang ST; Poon MC; Rustagi PK
    Am J Med; 1991 May; 90(5):639-45. PubMed ID: 1903026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete fibrin formation and highly elevated Factor XIII activity in multiple myeloma.
    Klingemann HG; Egbring R; Havemann K
    Scand J Haematol; 1981 Oct; 27(4):253-62. PubMed ID: 6810448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide.
    Tosetto A; Rodeghiero F; Gatto E; Manotti C; Poli T
    Am J Hematol; 1995 Jan; 48(1):34-9. PubMed ID: 7832189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
    Seiving B; Henriksson P; Stenberg P; Nilsson IM
    Br J Haematol; 1992 Oct; 82(2):414-6. PubMed ID: 1419823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
    Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
    Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
    Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series.
    Tone KJ; James TE; Fergusson DA; Tinmouth A; Tay J; Avey MT; Kilty S; Lalu MM
    Transfus Med Rev; 2016 Jul; 30(3):123-31. PubMed ID: 27167905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.
    Lopaciuk S; Bykowska K; McDonagh JM; McDonagh RP; Yount WJ; Fuller CR; Cooperstein L; Gray A; Lorand L
    J Clin Invest; 1978 May; 61(5):1196-203. PubMed ID: 96136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.
    Ahmad F; Solymoss S; Poon MC; Berube C; Sullivan AK
    Br J Haematol; 1996 Jun; 93(3):700-3. PubMed ID: 8652397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired plasma factor XIII deficiencies.
    Tosetto A; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII: inherited and acquired deficiency.
    Board PG; Losowsky MS; Miloszewski KJ
    Blood Rev; 1993 Dec; 7(4):229-42. PubMed ID: 8130686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide.
    Nakamura S; Kato A; Sakata Y; Aoki N
    Br J Haematol; 1988 Mar; 68(3):313-9. PubMed ID: 3258529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review.
    Trabelsi B; Baccouche H; Eddhib J; Chakroun A; Sonia M
    Blood Coagul Fibrinolysis; 2024 Jul; 35(5):293-295. PubMed ID: 38973520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.